Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: Underlying mechanisms and modulation by adjunctive cytokine therapy

Journal of Clinical Virology

Volumn 26, Issue 2, 2003, Pages 247-263

  Kedzierska, Katherine ^a,c   Azzam, Rula ^a,c   Ellery, Philip ^a,b,c   Mak, Johnson ^a,d   Jaworowski, Anthony ^a,b   Crowe, Suzanne M ^a,b,c  

^a BURNET INSTITUTE   (Australia)

^b Natl Ctr for HIV Virology Research   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Complement phagocytosis; GM CSF; HIV 1; IFN gamma; IgG phagocytosis; Monocytes macrophages

Indexed keywords

CD4 ANTIGEN; COMPLEMENT RECEPTOR; CYTOKINE; FC RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANDIDA ALBICANS; CELL FUNCTION; CELL LINEAGE; CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOTHERAPY; LYMPHOCYTE COUNT; MACROPHAGE; MONOCYTE; MYCOBACTERIUM AVIUM; NONHUMAN; OPPORTUNISTIC INFECTION; PHAGOCYTOSIS; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; SIDE EFFECT; SIGNAL TRANSDUCTION; TARGET CELL; TOXOPLASMA GONDII;

ADJUVANTS, IMMUNOLOGIC; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CYTOKINES; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA, RECOMBINANT; MACROPHAGES; MODELS, IMMUNOLOGICAL; MONOCYTES; PHAGOCYTOSIS; RECEPTORS, COMPLEMENT; RECEPTORS, IGG; SIGNAL TRANSDUCTION;

EID: 0037322692     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(02)00123-3     Document Type: Article

References (103)

1. Aderem A., Underhill D. Mechanisms of phagocytosis in macrophages. Ann. Rev. Immunol. 17:1999;593-623.
2. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5; a RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage tropic HIV-1. Science. 272:1996;1955-1958.
3. Allen L.A., Aderem A. Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J. Exp. Med. 184:1996;627-637.
4. Armitage J. Emerging applications of recombinant human granulocyte-macrophage colony stimulating factor. Blood. 92:1998;4491-4508.
5. Baqui A.A., Meiller T.F., Zhang M., Falkler W.A.J. The effects of HIV viral load on the phagocytic activity of monocytes activated with lipopolysaccharide from oral microorganisms. Immunopharmacol. Immunotoxicol. 21:1999;421-438.
6. Bermudez L., Young L. Recombinant granulocyte macrophage colony stimulating factor activates human macrophages to inhibit grown or kill Mycobacterium avium complex. J. Leukoc. Biol. 48:1990;67-73.
7. Berton G., Lowell C. Integrin signalling in neutrophils and macrophages. Cell. Signal. 11:1999;621-635.
8. Biggs B.A., Hewish M., Kent S., Hayes K., Crowe S.M. HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii. J. Immunol. 154:1995;6132-6139.
9. Bishop A., Hall A. Rho GTPases and their effector proteins. Biochem. J. 348:2000;241-255.
10. Bravo-Cuellar A., Nowacki W., Vuillier F., de Saint-Martin J., Orbach-Arbouys S. The bactericidal capacity of peripheral blood monocytes from HIV positive patients may collapse very soon after the infection. Immunol. Lett. 31:1992;297-299.
11. Brites C., Gilbert M.J., Pedral-Sampaio D., Bahia F., Pedroso C., Alcantara A.P., Sasaki M.D., Matos J., Renjifo B., Essex M., Whitmore J.B., Agosti J.M., Badaro R. A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS. J. Infect. Dis. 182:2000;1531-1535.
12. Buyon J., Philips M., Merrill J., Slade S., Leszczynska-Piziak J., Abramson S. Differential phosphorylation of the beta2 integrin CD11b/CD18 in the plasma and specific granule membranes of neutrophils. J. Leukoc. Biol. 61:1997;313-321.
13. Calderwood D., Shattil S., Ginsberg M. Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling. J. Biol. Chem. 275:2000;22 607-22 610.
14. Cameron P.U., Granger D.L., Matthews T.J., Weinberg J.B. Human immunodeficiency virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryptococcal activity whereas HIV-infected alveolar macrophages retain normal activity. J. Infect. Dis. 170:1993;60-67.
15. Capsoni F., Minonzio F., Ongari A.M., Bonara P., Pinto G., Carbonelli V., Lazzarin A., Zanussi C. Fc receptors expression and function in mononuclear phagocytes from AIDS patients; modulation by IFN-gamma. Scand. J. Immunol. 39:1994;45-50.
16. Capsoni F., Minonzio F., Ongari A.M., Rigardi G.P., Lazzarin A., Zanussi C. Monocyte-derived macrophage function in HIV-infected subjects: in vitro modulation by rIFN-gamma and rGM-CSF. Clin. Immunol. Immunopathol. 62:1992;176-182.
17. Caron E., Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science. 282:1998;1717-1721.
18. Chan H.T., Kedzierska K., O'Mullane J., Crowe S.M., Jaworowski A. Quantifying complement-mediated phagocytosis by human monocyte-derived macrophages. Immunol. Cell Biol. 79:2001;429-435.
19. Chatila T., Geha R., Arnaout M. Constitutive and stimulus-induced phosphorylation of CD11b/CD18 leukocyte adhesion molecules. J. Cell Biol. 109:1989;3435-3444.
20. Chaturvedi S., Frame P., Newman S.L. Macrophages from human immunodeficiency virus positive persons are defective in host defence against Histoplasma capsulatum. J. Infect. Dis. 171:1995;320-327.
21. Chimini G., Chavrier P. Function of Rho family proteins in actin dynamics during phagocytosis and engulfment. Nat. Cell Biol. 2:2000;E191-E196.
22. Coleman D.L., Chodakewitz J.A., Bartiss A.H., Mellors J.W. Granulocyte-macrophage colony-stimulating factor enhances selective effector functions of tissue-derived macrophages. Blood. 72:1988;573-578.
23. Crowe S.M. Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection. Aust. N. Z. J. Med. 25:1995;777-783.
24. Crowe S.M., Mills J., McGrath M.S. Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages. AIDS Res. Hum. Retroviruses. 3:1987;135-145.
25. Crowe S.M., Sonza S. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J. Leukoc. Biol. 68:2000;345-350.
26. Crowe S.M., Vardaxis N.J., Kent S.J., Maerz A.L., Hewish M.J., McGrath M.S., Mills J. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J. Leukoc. Biol. 56:1994;318-327.
27. Crowley M.T., Costello P.S., Fitzer-Attas C.J., Turner M., Meng F., Lowell C., Tybulewicz V.L., DeFranco A.L. A critical role for Syk in signal transduction and phagocytosis mediated by Fcgamma receptors on macrophages. J. Exp. Med. 186:1997;1027-1039.
28. Daeron M. Fc receptor biology. Annu. Rev. Immunol. 15:1997;203-234.
29. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.U.S., Bradley A., Stewart T.A. Multiple defects of immune cell function in mice disrupted with interferon-gamma genes. Science. 259:1993;1739-1742.
30. Deacon N.J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D.J., McPhee D.A., Greenway A.L., Ellett A., Chatfield C., Lawson A., Crowe S.M., Maerz A., Sonza S., Learmont J., Sullivan S., Cunningham A., Dwyer D., Dowton D., Mills J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 270:1995;988-991.
31. Delemarre F., Stevenhagen A., Kroon F., van Eer M., Meenhorst P., Furth R. Reduced toxoplasmastatic activity of monocytes and monocyte-derived macrophages from AIDS patients is mediated via prostaglandin E2. AIDS. 9:1995;441-445.
32. Dobmeyer T.S., Raffel B., Dobmeyer J.M., Findhammer S., Klein S.A., Kabelitz D., Hoelzer D., Helm E.B., Rossol R. Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts. Eur. J. Med. Res. 1:1995;9-15.
33. Eischen A., Vincent F., Bergerat J., Louis B., Faradji A., Bohbot A., Oberline F. Long term cultures of human monocytes in vitro. Impact of GM-CSF on survival and differentiation. J. Immunol. Methods. 143:1991;209-221.
34. Elbim C., Pillet S., Prevost M.H., Preira A., Girard P.M., Rogine N., Matusani H., Hakim J., Israel N., Gougerot-Pocidalo M.A. Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load. J. Virol. 73:1999;4561-4566.
35. Embretson J., Zupancic M., Ribas J.L., Burke A., Racz P., Tenner-Racz K., Haase A. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 362:1993;359-362.
36. Estevez M.E., Ballart I.J., Diez R.A., Planes D.N., Scaglione C., Sen L. Early defect of phagocytic cell function in subjects at risk for acquired immunodeficiency syndrome. Scand. J. Immunol. 24:1986;215-221.
37. Eversole L.R., Fleischmann J., Baldwin G.C., Sapp J.P. The effects of human immunodeficiency virus infection on macrophage phagocytosis of Candida. Oral. Microbiol. Immunol. 9:1994;55-59.
38. Fearon D.T. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med. 152:1980;20-30.
39. Finzi D., Hermankova M., Pierson T., Carruth L.M., Buck C., Chaisson R.E., Quinn T.C., Chadwick K., Margolick J., Brookmeyer R., Gallant J., Markowitz M., Ho D.D., Richman D.D., Siliciano R.F. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 278:1997;295-1300.
40. Fitzer-Attas C.J., Lowry M., Crowley M.T., Finn A.J., Meng F., DeFranco A.L., Lowell C.A. Fcgamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn. J. Exp. Med. 191:2000;669-682.
41. Gordon S.B., Molyneux M.E., Boeree M.J., Kanyanda S., Chaponda M., Squire S.B., Read R.C. Opsonic phagocytosis of Streptococcus pneumoniate by alveolar macrophages is not impaired in human immunodeficiency virus-infected Malawian adults. J. Infect. Dis. 184:2001;1345-1349.
42. Greenberg S. Signal transduction of phagocytosis. Trends Cell Biol. 5:1995;93-99.
43. Greenberg S., Chang P., Silverstein S.C. Tyrosine phosphorylation of the gamma subunit of Fc gamma receptors, p72syk, and paxillin during Fc receptor-mediated phagocytosis in macrophages. J. Biol. Chem. 269:1994;3897-3902.
44. Herrmann J.L., Dubois N., Fourgeaud M., Basset D., Lagrange P.H. Synergic inhibitory activity of amphotericin-B and gamma interferon against Cryptococcus neoformans in murine macrophages. J. Antimicrob. Chemother. 34:1994;1051-1058.
45. Hewish M.J., Meikle A.M., Hunter S.D., Crowe S.M. Quantifying phagocytosis of Mycobacterium avium complex by human monocytes in whole blood. Immunol. Cell Biol. 74:1996;306-312.
46. Ho D.D. Toward HIV eradication or remission: the tasks ahead. Science. 280:1998;1866-1867.
47. Huang S., Hendriks S., Althhage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R.M., Aguet M. Immune response in mice that lack the interferon-gamma receptor. Science. 259:1993;1742-1745.
48. Indik Z.K., Park J.G., Pan X.Q., Schreiber A.D. Induction of phagocytosis by a protein tyrosine kinase. Blood. 85:1995;1175-1180.
49. Joiner K.A., Fuhrman S.A., Miettinen H.M., Kasper L.H., Mellman I. Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts. Science. 249:1990;641-646.
50. Jordan C.A., Watkins B.A., Kufta C., Dubois-Dalcq M. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J. Virol. 65:1991;736-742.
51. Kaplan L., Kahn J., Crowe S., Northfelt D., Neville P., Grossberg H., Abrams D., Tracey J., Mills J., Volberding P. Clinical and virologic effects of recombinant human granulocyte macrophage colony stimulating factor (rGM-CSF) in patients receiving chemotherapy for HIV associated non-Hodgkin's lymphoma; results of a randomized trial. J. Clin. Oncol. 9:1991;929-940.
52. Kedzierska K., Crowe S.M. Cytokines and HIV-1: interactions and clinical implications. Antivir. Chem. Chemother. 12:2001;133-145.
53. Kedzierska K., Ellery P., Mak J., Lewin S.R., Crowe S.M., Jaworowski A. HIV-1 downmodulates gamma signalling chain of Fcgamma receptor in human macrophages: a possible mechanism for inhibition of phagocytosis. J. Immunol. 168:2002;2895-2903.
54. Kedzierska K., Mak J., Jaworowski A., Greenway A., Violo A., Chan H.T., Hocking J., Purcell D., Sullivan S., Mills J., Crowe S.M. nef-deleted HIV-1 inhibits phagocytosis by monocyte-derived macrophages in vitro but not by peripheral blood monocytes in vivo. AIDS. 15:2001;945-955.
55. Kedzierska K., Mak J., Mijch A., Cooke I., Rainbird M., Roberts S., Paukovics G., Jolley D., Lopez A., Crowe S.M. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo. J. Infect. Dis. 181:2000;390-394.
56. Kedzierska K., Vardaxis N.J., Jaworowski A., Crowe S.M. Fc gamma R-mediated phagocytosis by human macrophages involves Hck, Syk, and Pyk2 and is augmented by GM-CSF. J. Leukoc. Biol. 70:2001;322-328.
57. Kesson A.M., Fear W.R., Kazazi F., Mathijs J.M., Chang J., King N.J., Cunningham A.L. Human immunodeficiency virus type 1 infection of human placental macrophages in vitro. J. Infect. Dis. 168:1993;571-579.
58. Koziel H., Eichbaum Q., Kruskal B.A., Pinkston P., Rogers R.A., Armstrong M.Y., Richards F.F., Rose R.M., Ezekowitz R.A. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J. Clin. Invest. 102:1998;1332-1344.
59. Krown S.E., Paredes J., Bundow D., Polsky B., Gold J.W., Flomenberg N. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS. J. Clin. Oncol. 10:1992;1344-1351.
60. Le Page C., Genin P., Baines M., Hiscott J. Interferon activation and innate immunity. Rev. Immunogenet. 2:2000;374-386.
61. Learmont J., Geczy A., Mills J., Ashton L., Raynes-Greenow C., Garsia R., Dyer W., McIntyre L., Oelrichs R., Rhodes D., Deacon N., Sullivan J. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N. Engl. J. Med. 340:1999;1715-1722.
62. Learmont J., Tindall B., Evans L., Cunningham A., Wells J., Penny R., Kaldor J., Cooper D.A. Long term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet. 340:1992;863-867.
63. Lewin S.R., Sonza S., Irving L.B., McDonald C.F., Mills J., Crowe S.M. Surface CD4 is critical to in vitro HIV infection of human alveolar macrophages. AIDS Res. Hum. Retroviruses. 12:1996;877-883.
64. Lopez A., Shannon M., Hercus T., Nicola N., Cambareri B., Dottore M., Layton M., Eglington L., Vadas M. Residue 21 of human granulocyte macrophage colony stimulating factor is critical for biological activity and for high but not low affinity binding. EMBO J. 11:1992;909-916.
65. Massol P., Montcourrier P., Guillemot J.C., Chavrier P. Fc receptor-mediated phagocytosis requires CDC42 and Rac1. EMBO J. 17:1998;6219-6229.
66. McElrath M.J., Pruett J.E., Cohn Z.A. Mononuclear phagocytes of blood and bone marrow; comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc. Natl. Acad. Sci. USA. 86:1989;675-679.
67. Murphy P.M., Lane C.H., Gallin J.I., Fauci A.S. Marked disparity in incidence in bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 and interferon-gamma. Ann. Intern. Med. 108:1988;36-41.
68. Murray H. Current and future clinical applications of interferon-gamma in host antimicrobial defense. Intensive Care Med. 4:1996;S456-S461.
69. Murray H.W., Gellene R.A., Libby D.M., Rothermel C.D., Rubin B.Y. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J. Immunol. 135:1985;2457.
70. Murray H.W., Scavuzzo D., Jacobs J.L., Kaplan M.H., Libby D.M., Schindler J., Roberts R.B. In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes. J. Immunol. 138:1987;2457-2462.
71. Murray H.W., Spitalny G.L., Nathan C.F. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon gamma. J. Immunol. 134:1985;619-1622.
72. Musher D.M., Watson D.A., Nickeson D., Gyorkey F., Lahart C., Rossen R.D. The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages. Am. J. Med. Sci. 299:1990;158-163.
73. Nathan C.F., Murray H.W., Wiebe M.E., Rubin B.Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:1983;670.
74. Newman S.L., Gootee L. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect. Immunol. 60:1992;4593-4597.
75. Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., Levin M. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infections. N. Engl. J. Med. 335:1996;1941-1947.
76. Nielsen H., Kharazmi A., Faber V. Blood monocyte and neutrophil functions in the acquired immune deficiency syndrome. Scand. J. Immunol. 24:1986;291-296.
77. Nottet H.S.L.M., de Graaf L., de Vos N.M., Bakker L.J., van Strijp J.A.G., Visser M.R., Verhoef J. Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection. J. Infect. Dis. 168:1993;84-91.
78. Olafsson K., Smith M.S., Marshburn P., Carter S.G., Haskill S. Variation of HIV infectibility of macrophages as a function of donor, stage of differentiation, and site of origin. J. Acquir. Immune Defic. Syndr. 4:1991;154-164.
79. Orenstein J.M., Fox C., Wahl S.M. Macrophages as a source of HIV during opportunistic infections. Science. 276:1997;1857-1861.
80. Park J.G., Murray R.K., Chien P., Darby C., Schreiber A.D. Conserved cytoplasmic tyrosine residues of the gamma subunit are required for a phagocytic signal mediated by Fc gamma RIIIA. J. Clin. Invest. 92:1993;2073-2079.
81. Peck R. Gamma interferon induces monocyte killing of Listeria monocytogenes by an oxygen-dependent pathway; alpha- or beta-interferons by oxygen-independent pathways. J. Leukoc. Biol. 46:1991;434-440.
82. Perno C.F., Cooney D.A., Gao W.Y., Hao Z., Johns D.G., Foli A., Hartman N.R., Calio R., Broder S., Yarchoan R. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocytes/macrophages. Blood. 80:1992;995-1003.
83. Pittis M.G., Sternik G., Sen L., Diez R.A., Planes N., Pirola D., Estevez M.E. Impaired phagolysosomal fusion of peripheral blood monocytes from HIV infected subjects. Scand. J. Immunol. 38:1993;423-427.
84. Pos O., Stevenhagen A., Meenhorst P.L., Kroon F.P., van Furth R. Impaired phagocytosis of Staphylococcus aureus by granolocytes and monocytes of AIDS patients. Clin. Exp. Immunol. 88:1992;23-28.
85. Reed S.G., Da Silva J.S., Ho J.L., Koehler J.K., Russo D.M., Pihl D.L., Coombs R.W. Cytokine activation of human macrophages infected with HIV-1 to inhibit intracellular protozoa. J. Acquir. Immune Defic. Syndr. 5:1992;666-675.
86. Reed S.G., Nathan C.F., Pihl D.L., Rodricks P., Shanebeck K., Conlon P.J., Grabstein K.H. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma. J. Exp. Med. 166:1987;1734-1746.
87. Rich E.A., Chen I.S.Y., Zack J.A., Leonard M.L., O'Brien W.A. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J. Clin. Invest. 89:1992;176-183.
88. Riddell L.A., Pinching A.J., Hill S., Hg T.T., Arbe E., Lapham G.P., Ash S., Hillman R., Tchamouroff S., Denning D.W., Parkin J.M. A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease. AIDS Res. Hum. Retroviruses. 17:2001;789-797.
89. Roilides E., Blake C., Holmes A., Pizzo P.A., Walsh T.J. Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae. J. Med. Vet. Mycol. 34:1996;63-66.
90. Roilides E., Holmes A., Blake C., Pizzo P.A., Walsh T.J. Defective antifungal activity of monocyte derived macrophages from human immunodeficiency virus infected children against Aspergillus fumigatus. J. Infect. Dis. 168:1993;1562-1565.
91. Schlesinger L.S., Horwitz M.A. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18) and CR4(CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of the bacterium. J. Immunol. 147:1991;1983-1993.
92. Schmitt M.P., Steffan A.M., Gendrault J.L., Jaeck D., Royer C., Schweitzer C., Beyer C., Schmit C., Auberti A.M., Kim A. Multiplication of human immunodeficiency virus in primary cultures of human Kupffer cells-possible role of liver macrophage infection in the physiopathology of AIDS. Res. Virol. 141:1990;143-152.
93. Schoenwalder S., Burridge K. Bidirectional signaling between the cytoskeleton and integrins. Curr. Opin. Cell Biol. 11:1999;274-286.
94. Schuitemaker H., Kootstra N.A., Koppelman M.H., Bruisten S.M., Huisman H.G., Tersmette M., Miedema F. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J. Clin. Invest. 89:1992;1154-1160.
95. Smith P., Lamerson C., Banks S., Saini S., Wahl L., Calderone B., Wahl S. Granulocyte macrophage colony stimulating factor augments human monocyte fungicidal activity for Candida albicans. J. Infect. Dis. 161:1990;999-1005.
96. Sonza S., Maerz A., Deacon N., Meanger J., Mills J., Crowe S. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J. Virol. 70:1996;3863-3869.
97. Squires K.E., Brown S.T., Armstrong D., Murphy W.F., Murray H.W. Interferon-gamma treatment for Mycobacterium avium-intracellulare complex bacillaemia in patients with AIDS. J. Infect. Dis. 166:1992;686-687.
98. Thomas C.A., Weinberger O.K., Ziegler B.L., Greenberg S., Schieren I., Silverstein S.C., El Khoury J. Human immunodeficiency virus-1 env impairs Fc receptor-mediated phagocytosis via a cyclic adenosine monophosphate-dependent mechanism. Blood. 90:1997;3760-3765.
99. Vazquez J.A., Gupta S., Villanueva A. Potential utility of recombinant human GM-CSF as adjunctive treatment of refractory oropharyngeal candidiasis in AIDS patients. Eur. J. Clin. Microbiol. Infect. Dis. 17:1998;781-783.
100. Wehle K., Schirmer M., Dunnebacke-Hinz J., Kupper T., Pfitzer P. Quantitative differences in phagocytosis and degradation of Pneumocystis carinii by alveolar macrophages in AIDS and non-HIV patients in vivo. Cytopathology. 4:1993;231-236.
101. Wright S.D., Levin S.M., Jong M.T., Chad Z., Kabbash L.G. CR3 (CD11b/CD18) express one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysoccharide. J. Exp. Med. 169:1989;175-183.
102. Wright S.D., Rao P.E., Van Voorhis W.C., Craigmle L.S., Lida K., Talle M.A., Westberg E.F., Goldstein G., Silverstein S.C. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. 80:1983;5699-5703.
103. Zhou X., Li J. Macrophage-enriched myristoylated alanine-rich C kinase substrate and its phosphorylation is required for the phorbol ester-stimulated diffusion of beta 2 integrin molecules. J. Biol. Chem. 275:2000;20 217-20 222.